News you can use: health & drug safety updates


  • July 16, 2015
    The next National Prescription Drug Take-Back Day will be held on September 26 from 10 a.m. to 2 p.m., the Drug Enforcement Administration (DEA) has announced. The National Prescription Drug Take-Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications. Collection sites will be announced on September 1, the DEA said. During the ninth Prescription Drug Take-Back Day last September, DEA and its partners collected 209 tons of pills.
  • July 9, 2015
    The Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on our comprehensive review of new safety information, we are requiring updates to the drug labels of all prescription NSAIDs. As is the case with current prescription NSAID labels, the Drug Facts labels of over-the-counter (OTC) non-aspirin NSAIDs already contain information on heart attack and stroke risk. We will also request updates to the OTC non-aspirin
  • July 8, 2015
    Here are 10 types of medications that can cause insomnia. If you are taking any of them and having sleep problems, you should talk with your doctor or pharmacist about adjusting the dosage, changing to another type of medication, or trying an alternative treatment or therapy. 1. Alpha-blockers 2. Beta-blockers 3. Corticosteroids 4. SSRI antidepressants 5. ACE inhibitors 6. ARBs 7. Cholinesterase inhibitors 8. H1 antagonists 9. Glucosamine/chondroitin 10. Statins (Source: AARP)
  • July 7, 2015
    The Office of the Assistant Secretary for Health, in collaboration with the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services, recently released a new set of training materials for health professionals. The HHS Education and Training Resources on Multiple Chronic Conditions (MCC) for the Healthcare Workforce will provide health professionals with education to care for people living with multiple chronic conditions for use by healthcare curriculum developers, educators, trainers, students, and practitioners. The
  • July 7, 2015
    FDA wants to make sure that the next time your child has ear pain requiring a prescription drug, the product has been approved by FDA as safe and effective. That’s why FDA is notifying companies to stop marketing 16 unapproved prescription drugs labeled to relieve ear pain and swelling. These ear drops contain active ingredients such as benzocaine and hydrocortisone but have not been evaluated by FDA for safety, effectiveness and quality. For years, health care providers have prescribed—and
  • July 1, 2015
    ISSUE: FDA is investigating the safety of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including slowed or difficult breathing. AUDIENCE: Family Practice, Pediatrics, Surgery, Patient Children, especially those who already have breathing problems, may be more susceptible to these serious side effects. In 2013, FDA warned against using codeine in children who recently had surgery to remove their tonsils and/or adenoids.
  • July 1, 2015

    APhA Pharmacy Today

  • June 30, 2015
    The Veterans Health Administration, part of the Department of Veterans Affairs (VA), has produced a series of YouTube videos to educate individuals on the safe administration of naloxone, an emergency opioid-overdose antidote that helps prevent overdose deaths. The videos show how to recognize the signs of an opioid overdose and administer intranasal or intramuscular naloxone, or use
  • June 17, 2015
    The percentage of boys ages 5-18 taking one or more behavioral medication in 2012 was more than double that of girls: 6.0 percent versus 2.3 percent. Highlights:
  • In 2012, 4.2 percent of children and teenagers ages 5–18 took one or more behavioral medications (2.42 million of 58.35 million children and teenagers).
  • The percentage of boys ages 5–18 taking one or more behavioral medications was more than double the percentage of girls ages 5–18 taking one or more behavioral medications (6.0 percent versus 2.3 percent) in 2012.
  • June 15, 2015
    A recent study has drawn a connection between new use of sedative hypnotics and higher risk of motor vehicle crashes. The new user cohort study involved more than 409,000 adults in an integrated health care system in Washington state. Researchers used proportional hazards regression to estimate the risk of crash associated with three sedatives. Nearly 6% of patients were given new sedative prescriptions, with 11,197 person–years of exposure. Compared with nonuse, new users of sedatives were linked to a greater risk of crashes. The risk estimates for the three drugs were
  • Pages